Oxford MESTar, in collaboration with the The Cell and Gene Therapy (CGT) Catapult and AK (Suzhou) Biomedical, has been awarded a grant from the Innovate UK-Jiangsu Industrial Challenge Programme, a project set up to stimulate economic growth, and foster ties between China and the UK. Through the grant, CGT Catapult, Oxford MEStar, a UK based bioengineering company specialising in process automation for the regenerative medicine and cell therapy sector, and AK (Suzhou) Biomedical, a Chinese biotech firm specialising in products and services for clinical applications aim to support the development of a novel manufacturing system intended to dramatically reduce the cost of production of CAR-T therapy, a highly promising cancer treatment.

The full press release is available here: https://ct.catapult.org.uk/news-media/general-news/oxford-mestar-ak-suzhou